Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 36Gynecologic 13Head & Neck 9Thoracic 8Dermatologic 8Genitourinary 7Lymphoid 4Other solid neoplasm 3Breast 3NET 2Endocrine 2Sarcoma 1CNS 1

Conditions

Brain Neoplasms 2310Glioblastoma 2014Glioma 1399Central Nervous System Neoplasms 692Astrocytoma 667Neuroblastoma 647Gliosarcoma 480Neoplasms 405Oligodendroglioma 404Breast Neoplasms 327Medulloblastoma 307Carcinoma, Non-Small-Cell Lung 255Meningioma 229Recurrence 224Sarcoma 214Melanoma 206Neoplasm Metastasis 202Lung Neoplasms 199Ependymoma 199Neurofibromatosis 1 169Lymphoma 161Meningeal Carcinomatosis 138Osteosarcoma 134Ovarian Neoplasms 132Wilms Tumor 123Precursor Cell Lymphoblastic Leukemia-Lymphoma 123Head and Neck Neoplasms 117Lymphoma, Non-Hodgkin 116Diffuse Intrinsic Pontine Glioma 113Rhabdomyosarcoma 106

Interventions

lentiviral minigene vaccine of COVID-19 coronavirus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Microsatellite Instability × CNS × Clear all
NCT06043232 2023-09-21

MMR/MSI Phenotypes in Prediction of Tumor Vaccine Benefit for Gliomas

Huashan Hospital

Unknown
360 enrolled
CNS

Glioblastoma, Glioma, Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡